Serotonin syndrome following left ventricular assist device implantation: A report and institution-specific strategy for prevention.

Publication/Presentation Date

12-1-2019

Abstract

Serotonin syndrome is a potentially lethal complication of antidepressant therapy. Cardiac surgical patients are at particularly high risk of serotonin syndrome due to the prevalence of depression in patients with advanced cardiac disease, many of whom receive multiple serotonergic agents in the perioperative period. Here, we describe a case of postoperative serotonin syndrome following methylene blue administration for perioperative vasoplegia during left ventricular assist device implantation. We additionally describe an institution-specific strategy to minimize future occurrences of serotonin syndrome in this high-risk population.

Volume

20

Issue

6

First Page

218

Last Page

220

ISSN

1878-5409

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

PubMedID

31762837

Department(s)

Administration and Leadership

Document Type

Article

Share

COinS